Aurora Cannabis Inc. R (21P.F) Financials

21P.F Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 481.7 million 128.9 million
Sept. 30, 2025 463.2 million 116.1 million
June 30, 2025 522.4 million 155.4 million
March 31, 2025 548.9 million 157.1 million

21P.F Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 6.8 million -342345
Sept. 30, 2025 -28.6 million 3.0 million
June 30, 2025 3.2 million 1.4 million
March 31, 2025 -401075 1.5 million

21P.F Net Income

No data available :(

21P.F Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 - - 24.4 million
Sept. 30, 2025 - - 24.8 million
June 30, 2025 - - 26.1 million
March 31, 2025 - - 27.6 million

21P.F Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 35.2 million
Sept. 30, 2025 34.6 million
June 30, 2025 35.1 million
March 31, 2025 36.2 million

21P.F Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 3.7 million 809574 24.9 million -
Sept. 30, 2025 3.9 million 553227 28.6 million -
June 30, 2025 3.1 million 516924 28.2 million -
March 31, 2025 2.8 million 505367 31.2 million -

21P.F Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 58.5 million 29.6 million
Sept. 30, 2025 55.3 million 35.5 million
June 30, 2025 61.1 million 43.7 million
March 31, 2025 58.3 million 44.2 million

21P.F

Price: €2.92

52 week price:
2.77
5.62

Earnings Per Share: -0.94 EUR

P/E Ratio: -3.19

Exchange: FRA

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 172.4 million

Links: